International Clinical Trial: Hypoallergenic birch pollen ointment for patients with PFAS ; a placebo-controlled, double-blind RCT

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCTs031250401) titled 'Hypoallergenic birch pollen ointment for patients with PFAS ; a placebo-controlled, double-blind RCT' on Oct. 1.

Study Type: Interventional

Study Design: randomized controlled trial, double blind, placebo control, parallel assignment, treatment purpose

Primary Sponsor: Komatsuzaki Keiko

Condition: Pollen-Food Allergy Syndrome(Birch)

Intervention:

- According to the allocation results, the study drug (double-blind: BP-GMC ointment or placebo ointment) will be applied to both nasal cavities once a day from Day 1 to Day 14, and then once a week for 12 weeks.

- The active drug (BP-GMC ointment) will be a...